JOHN L. HIGGINS - 07 Aug 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
07 Aug 2025
Transactions value $
$110,074
Form type
4
Filing time
11 Aug 2025, 19:06:29 UTC
Previous filing
18 Jun 2025
Next filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HIGGINS JOHN L Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed 11 Aug 2025 0001208906

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $110,073 +5,040 +8.4% $21.84 65,236 07 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (Right to Buy) Options Exercise $0 -5,040 -100% $0 0 07 Aug 2025 Common Stock 5,040 $21.84 Direct
holding TECH Stock Option (Right to Buy) 15,940 07 Aug 2025 Common Stock 15,940 $25.3 Direct
holding TECH Stock Option (Right to Buy) 12,500 07 Aug 2025 Common Stock 12,500 $31.26 Direct
holding TECH Stock Option (Right to Buy) 7,592 07 Aug 2025 Common Stock 7,592 $44.96 Direct
holding TECH Stock Option (Right to Buy) 8,044 07 Aug 2025 Common Stock 8,044 $50.41 Direct
holding TECH Stock Option (Right to Buy) 6,028 07 Aug 2025 Common Stock 6,028 $63.92 Direct
holding TECH Stock Option (Right to Buy) 2,532 07 Aug 2025 Common Stock 2,532 $128.81 Direct
holding TECH Stock Option (Right to Buy) 3,460 07 Aug 2025 Common Stock 3,460 $73.94 Direct
holding TECH Stock Option (Right to Buy) 3,937 07 Aug 2025 Common Stock 3,937 $61.51 Direct
holding TECH Stock Option (Right to Buy) 3,511 07 Aug 2025 Common Stock 3,511 $68.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.